Balance Sheet
Cash Flow Statement
AmortizationAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evogene (EVGN) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Evogene (EVGN) over the last 13 years, with Q3 2025 value amounting to -$10.3 million.

  • Evogene's Net Cash Flow fell 18386.89% to -$10.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.1 million, marking a year-over-year decrease of 12414.05%. This contributed to the annual value of $34.0 million for FY2024, which is 52669.85% up from last year.
  • Per Evogene's latest filing, its Net Cash Flow stood at -$10.3 million for Q3 2025, which was down 18386.89% from $860000.0 recorded in Q2 2025.
  • Evogene's 5-year Net Cash Flow high stood at $17.2 million for Q3 2022, and its period low was -$10.3 million during Q3 2025.
  • Over the past 5 years, Evogene's median Net Cash Flow value was $4.2 million (recorded in 2022), while the average stood at $3.3 million.
  • As far as peak fluctuations go, Evogene's Net Cash Flow skyrocketed by 114996.69% in 2021, and later tumbled by 24100.6% in 2023.
  • Quarter analysis of 5 years shows Evogene's Net Cash Flow stood at $10.0 million in 2021, then crashed by 130.64% to -$3.1 million in 2022, then skyrocketed by 269.67% to $5.2 million in 2023, then skyrocketed by 152.56% to $13.1 million in 2024, then crashed by 178.82% to -$10.3 million in 2025.
  • Its Net Cash Flow stands at -$10.3 million for Q3 2025, versus $860000.0 for Q2 2025 and -$7.8 million for Q1 2025.